+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bronchiolitis Obliterans Syndrome Market - Global Forecast 2026-2032- Product Image
Bronchiolitis Obliterans Syndrome Market - Global Forecast 2026-2032- Product Image
New

Bronchiolitis Obliterans Syndrome Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011463
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bronchiolitis obliterans syndrome market presents a rapidly evolving environment, shaped by the complexities of small airway inflammation and mounting operational pressures that influence treatment, procurement, and healthcare delivery models.

Market Snapshot: Growth Landscape for Bronchiolitis Obliterans Syndrome

The Bronchiolitis Obliterans Syndrome Market grew from USD 79.43 million in 2025 to USD 92.55 million in 2026. It is expected to continue growing at a CAGR of 8.60%, reaching USD 141.54 million by 2032. Market expansion is driven by a combination of scientific advances, enhanced clinical awareness, and shifting procurement practices. Emerging therapy classes, investment in diagnostics, and transformations in care delivery contribute to stronger market positioning for stakeholders.

Scope & Segmentation

  • Therapeutic Classes: Corticosteroids (inhaled and systemic), immunosuppressants (including antimetabolites and calcineurin inhibitors), and macrolides (azithromycin, clarithromycin)
  • Procedural Pathways: Diagnostic and therapeutic bronchoscopy, single or double lung transplantation, comprehensive pulmonary rehabilitation protocols
  • Delivery Modalities: Inhalers, nebulizers, intravenous infusions, and oral administration via capsules or tablets
  • Care Settings: Hospital-owned and independent ambulatory surgery centers, general and specialty hospitals, pulmonology practices, and transplant centers
  • Distribution Networks: Hospital pharmacies, prescription and over-the-counter e-pharmacies, and retail pharmacy chains or independent outlets
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific—each region impacting clinical practice, procurement, and regulatory approaches
  • Technologies: Molecular diagnostics, advanced imaging, integrated electronic health records, real-world data registries

Key Takeaways

  • Care management is inherently complex, requiring multidisciplinary teams and integrated clinical protocols to address both immediate and long-term needs.
  • Advancements in diagnostics and therapy delivery allow for earlier intervention and more tailored treatment strategies, supporting personalized approaches.
  • Operational alignment between clinical care, procurement, and regulatory compliance is increasingly essential for seamless patient access to critical therapies.
  • Regional ecosystem differences—from specialized centers in the Americas to emerging infrastructure in Asia-Pacific—influence technology adoption and evidence priorities.
  • Stakeholders are prioritizing real-world evidence to substantiate therapeutic value, prompting pragmatic clinical and operational study designs.
  • Strategic partnerships between clinical providers, manufacturers, and distributors enable innovation in drug formulation, supply continuity, and patient support services.

Tariff Impact: Navigating Procurement and Supply Chain Shifts

Recent tariff policy changes in the United States have resulted in increased costs and reshaped procurement dynamics for bronchiolitis obliterans syndrome therapies and devices. Healthcare providers are diversifying sourcing channels, developing redundancy in supply planning, and refining contracting arrangements to buffer against volatility. Manufacturers reassess manufacturing locations and seek alternate suppliers, while procurement teams focus on budget impact mitigation and distribution continuity. Collaborative planning with regulatory affairs is critical to maintaining essential supplies and uninterrupted patient care.

Methodology & Data Sources

This analysis utilized a mixed-methods approach, drawing on structured interviews with healthcare professionals, literature review, and operational case studies. Additional inputs included regulatory documentation and tariff notifications, complemented by institutional examples of supply chain and clinical program adaptation. All findings underwent expert peer review for accuracy and practical relevance.

Bronchiolitis Obliterans Syndrome Market: Why This Report Matters

  • Enables senior leaders to benchmark evolving therapeutic options, procurement strategies, and care models against regional best practices and operational realities.
  • Supports long-term planning by highlighting clinical, technological, and supply chain factors that influence market positioning and risk mitigation.
  • Equips decision-makers with actionable segmentation frameworks and evidence-driven pathways for optimizing investment, service quality, and clinical impact.

Conclusion

Optimizing outcomes in bronchiolitis obliterans syndrome requires integrated care models, responsive procurement strategies, and continuous real-world data collection. Senior decision-makers who align clinical innovation with operational resilience are well-positioned to deliver value across today’s shifting market landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bronchiolitis Obliterans Syndrome Market, by Drug Class
8.1. Corticosteroids
8.1.1. Inhaled
8.1.2. Systemic
8.2. Immunosuppressants
8.2.1. Antimetabolites
8.2.2. Calcineurin Inhibitors
8.3. Macrolides
8.3.1. Azithromycin
8.3.2. Clarithromycin
9. Bronchiolitis Obliterans Syndrome Market, by Procedure Type
9.1. Bronchoscopy
9.2. Lung Transplantation
9.3. Pulmonary Rehabilitation
10. Bronchiolitis Obliterans Syndrome Market, by Delivery Mode
10.1. Inhalation
10.1.1. Inhalers
10.1.2. Nebulizers
10.2. Intravenous
10.2.1. Bolus
10.2.2. Infusion
10.3. Oral
10.3.1. Capsules
10.3.2. Tablets
11. Bronchiolitis Obliterans Syndrome Market, by End User
11.1. Ambulatory Surgery Centers
11.2. Hospitals
11.3. Specialty Clinics
11.3.1. Pulmonology Clinics
11.3.2. Transplant Centers
12. Bronchiolitis Obliterans Syndrome Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Online Pharmacies
12.3. Retail Pharmacies
13. Bronchiolitis Obliterans Syndrome Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Bronchiolitis Obliterans Syndrome Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Bronchiolitis Obliterans Syndrome Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Bronchiolitis Obliterans Syndrome Market
17. China Bronchiolitis Obliterans Syndrome Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Astellas Pharma Inc.
18.6. Bristol-Myers Squibb Company
18.7. F. Hoffmann-La Roche Ltd
18.8. GlaxoSmithKline plc
18.9. Mallinckrodt plc
18.10. Merck & Co., Inc.
18.11. Novartis AG
18.12. Omron Corporation
18.13. PARI GmbH
18.14. Pfizer Inc.
18.15. Sanofi S.A.
18.16. Sensirion AG
18.17. Takeda Pharmaceutical Company Limited
List of Figures
FIGURE 1. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SYSTEMIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SYSTEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ANTIMETABOLITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ANTIMETABOLITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CALCINEURIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AZITHROMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AZITHROMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CLARITHROMYCIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CLARITHROMYCIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BRONCHOSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BRONCHOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BRONCHOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY LUNG TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONARY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BOLUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BOLUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY BOLUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PULMONOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TRANSPLANT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY TRANSPLANT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 159. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 162. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 164. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 184. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 185. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 186. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 187. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 188. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 190. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. AFRICA BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 210. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 211. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 212. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 214. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 215. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 216. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 217. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 222. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 223. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 224. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 225. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 226. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 227. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 228. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 229. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 230. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 232. GCC BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 248. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 249. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 250. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 251. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 252. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 253. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 254. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 255. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 256. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 258. BRICS BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 261. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 262. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 263. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 264. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 265. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 266. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 267. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 268. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 269. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 271. G7 BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 274. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 275. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 276. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 277. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 278. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 279. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 280. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
TABLE 281. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 282. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 284. NATO BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY CORTICOSTEROIDS, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY MACROLIDES, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INHALATION, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES BRONCHIOLITIS OBLITERANS SYNDROME MARKET SIZE, BY INTRAVENOUS, 2018-2032 (U

Companies Mentioned

  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Mallinckrodt plc
  • Merck & Co., Inc.
  • Novartis AG
  • Omron Corporation
  • PARI GmbH
  • Pfizer Inc.
  • Sanofi S.A.
  • Sensirion AG
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Bronchiolitis Obliterans Syndrome Global Market Report 2025 - Product Image

Bronchiolitis Obliterans Syndrome Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Acute Lung Injury Treatment Market - Global Forecast 2025-2032 - Product Image

Acute Lung Injury Treatment Market - Global Forecast 2025-2032

  • Report
  • 181 Pages
  • Global
From
Bronchitis Treatment Market Report 2025 - Product Image

Bronchitis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report - Product Image

Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report

  • Report
  • 323 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis Market - Global Forecast 2025-2032 - Product Image

Idiopathic Pulmonary Fibrosis Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.